Rights and permissions
About this article
Cite this article
Gemcitabine regimens improve response rates in colorectal cancer. Inpharma Wkly. 1221, 11 (2000). https://doi.org/10.2165/00128413-200012210-00027
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-200012210-00027